These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12951129)

  • 21. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
    Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of 1,2,3,4-tetrahydropyrimido[1,2-a]benzimidazoles as novel class of corticotropin releasing factor 1 receptor antagonists.
    Kojima T; Mochizuki M; Takai T; Hoashi Y; Morimoto S; Seto M; Nakamura M; Kobayashi K; Sako Y; Tanaka M; Kanzaki N; Kosugi Y; Yano T; Aso K
    Bioorg Med Chem; 2018 May; 26(9):2229-2250. PubMed ID: 29459145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure-activity relationships of 8-(pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: potent, orally bioavailable corticotropin releasing factor receptor-1 (CRF1) antagonists.
    Gilligan PJ; Clarke T; He L; Lelas S; Li YW; Heman K; Fitzgerald L; Miller K; Zhang G; Marshall A; Krause C; McElroy JF; Ward K; Zeller K; Wong H; Bai S; Saye J; Grossman S; Zaczek R; Arneric SP; Hartig P; Robertson D; Trainor G
    J Med Chem; 2009 May; 52(9):3084-92. PubMed ID: 19361209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of a 7-arylaminobenzimidazole series as novel CRF1 receptor antagonists.
    Mochizuki M; Kori M; Kono M; Yano T; Sako Y; Tanaka M; Kanzaki N; Gyorkos AC; Corrette CP; Aso K
    Bioorg Med Chem; 2016 Oct; 24(19):4675-4691. PubMed ID: 27567079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of 4-chloro-2-(2,4-dichloro-6-methylphenoxy)-1-methyl-7-(pentan-3-yl)-1H-benzimidazole, a novel CRF
    Mochizuki M; Kojima T; Kobayashi K; Kotani E; Ishichi Y; Kanzaki N; Nakagawa H; Okuda T; Kosugi Y; Yano T; Sako Y; Tanaka M; Aso K
    Bioorg Med Chem; 2017 Mar; 25(5):1556-1570. PubMed ID: 28174066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor1 receptor antagonists.
    Chen C; Dagnino R; De Souza EB; Grigoriadis DE; Huang CQ; Kim KI; Liu Z; Moran T; Webb TR; Whitten JP; Xie YF; McCarthy JR
    J Med Chem; 1996 Oct; 39(22):4358-60. PubMed ID: 8893829
    [No Abstract]   [Full Text] [Related]  

  • 27. 8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonists.
    Gilligan PJ; He L; Clarke T; Tivitmahaisoon P; Lelas S; Li YW; Heman K; Fitzgerald L; Miller K; Zhang G; Marshall A; Krause C; McElroy J; Ward K; Shen H; Wong H; Grossman S; Nemeth G; Zaczek R; Arneric SP; Hartig P; Robertson DW; Trainor G
    J Med Chem; 2009 May; 52(9):3073-83. PubMed ID: 19361210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and structure-activity relationships of N3-pyridylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists.
    Hartz RA; Ahuja VT; Schmitz WD; Molski TF; Mattson GK; Lodge NJ; Bronson JJ; Macor JE
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1890-4. PubMed ID: 20176478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of benzoylpyrimidines as antagonists of the corticotropin-releasing factor-1 receptor.
    Webb TR; Moran T; Huang CQ; McCarthy JR; Grigoriadis DE; Chen C
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3869-73. PubMed ID: 15225687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyrazolo[1,5-a]pyrimidine CRF-1 receptor antagonists.
    Wustrow DJ; Capiris T; Rubin R; Knobelsdorf JA; Akunne H; Davis MD; MacKenzie R; Pugsley TA; Zoski KT; Heffner TG; Wise LD
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2067-70. PubMed ID: 9873487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and structure-affinity relationships of 4-(5-Aryl-1,2,3,6-tetrahydropyridino)pyrimidine derivatives as corticotropin-releasing factor(1) receptor antagonists.
    Kumagai T; Okubo T; Kataoka-Okubo H; Chaki S; Okuyama S; Nakazato A
    Bioorg Med Chem; 2001 May; 9(5):1349-55. PubMed ID: 11377192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and structure-activity relationship of imidazo[1,2-a]benzimidazoles as corticotropin-releasing factor 1 receptor antagonists.
    Han X; Pin SS; Burris K; Fung LK; Huang S; Taber MT; Zhang J; Dubowchik GM
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4029-32. PubMed ID: 15982881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, structural optimization, SAR, in silico prediction of physicochemical properties and pharmacological evaluation of novel & potent thiazolo[4,5-d]pyrimidine corticotropin releasing factor (CRF) receptor antagonists.
    Islam MR; Teleb M; Karageorgos V; Sakellaris S; Papadopoulos M; Pirmettis I; Fronczek FR; Liapakis G; Fahmy H
    Eur J Pharm Sci; 2022 Feb; 169():106084. PubMed ID: 34856350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of 3-phenylpyrazolo[4,3-b]pyridines via a convenient synthesis of 4-amino-3-arylpyrazoles and SAR of corticotropin-releasing factor receptor type-1 antagonists.
    Wilcoxen K; Huang CQ; McCarthy JR; Grigoriadis DE; Chen C
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3367-70. PubMed ID: 12951127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.
    Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB
    Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4-Aryl-2-anilinopyrimidines as corticotropin-releasing hormone (CRH) antagonists.
    Cocuzza AJ; Hobbs FW; Arnold CR; Chidester DR; Yarem JA; Culp S; Fitzgerald L; Gilligan PJ
    Bioorg Med Chem Lett; 1999 Apr; 9(7):1057-62. PubMed ID: 10230640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-arylaminothiazoles as high-affinity corticotropin-releasing factor 1 receptor (CRF1R) antagonists: synthesis, binding studies and behavioral efficacy.
    Dubowchik GM; Michne JA; Zuev D; Schwartz W; Scola PM; James CA; Ruediger EH; Pin SS; Burris KD; Balanda LA; Gao Q; Wu D; Fung L; Fiedler T; Browman KE; Taber MT; Zhang J
    Bioorg Med Chem Lett; 2003 Nov; 13(22):3997-4000. PubMed ID: 14592493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor1 receptor antagonist.
    Chen YL; Mansbach RS; Winter SM; Brooks E; Collins J; Corman ML; Dunaiskis AR; Faraci WS; Gallaschun RJ; Schmidt A; Schulz DW
    J Med Chem; 1997 May; 40(11):1749-54. PubMed ID: 9171885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.
    Myers DA; Trinh JV; Myers TR
    Mol Cell Endocrinol; 1998 Sep; 144(1-2):21-35. PubMed ID: 9863624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of 2-anilino-3-phenylsulfonyl-6-methylpyridines as corticotropin-releasing factor1 receptor ligands.
    Hartz RA; Arvanitis AG; Arnold C; Rescinito JP; Hung KL; Zhang G; Wong H; Langley DR; Gilligan PJ; Trainor GL
    Bioorg Med Chem Lett; 2006 Feb; 16(4):934-7. PubMed ID: 16297619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.